Meeting support for HIV Evolution and Dynamics

描述（由申请人提供）：艾滋病毒演变和动态会议是一个小型的年度艾滋病毒会议，有十年的历史。这次会议为从事数据分析、数学建模和艾滋病毒进化分析的人提供了一个特别的机会，让他们聚在一起讨论新的研究，包括新的研究及其影响，以及可以应用于艾滋病毒的新分析工具和方法。数学和统计方面的工作可以更深入地讨论比可能在更大的艾滋病毒会议，主要集中在实验和临床演示。从历史上看，这次会议在欧洲和美国之间交替举行，以便大西洋两岸的研究人员能够更多地参加会议。对于直接参与数据分析的艾滋病毒科学家来说，这可能是一年中最重要的会议之一。会议吸引了模拟体内动力学和疾病进展的个人，考虑到流行病历史，免疫学和疫苗策略的艾滋病毒全球变异，以及研究耐药性出现的个人。讲座和海报的范围从重要的新研究，有复杂的方面，可能会提出更多的从传统的观点，但从分析的角度进行了讨论;数学为导向的会谈，有机会进入更多的细节比是适当的，在典型的艾滋病毒生物学会议;和会谈，从科学家以外的艾滋病毒领域谁开发新的分析方法，可能有用的是带入艾滋病毒研究领域。大约有100至150名科学家参加;这个数字过去取决于地点。有充分的时间进行讨论和建立联系，以促进和扩大正在进行的研究，并发起新的合作努力。会议传统上得到了OAR和CDC的支持，并通过行业和主要组织者在任何一年的筹款努力获得补充资金。这是第一次，我们要求继续，从2003年春季在箭头湖会议中心举行的会议开始，从NIH-NIAID五年的支持。UCSD继续医学教育办公室已提出支持会议的财务和组织基础设施，为期五年，我们正在申请资金，并将直接与主要科学组织者合作，无论他或她的家乡机构。

DESCRIPTION (provided by applicant): The HIV Evolution and Dynamics Meeting is a small annual HIV meeting with a ten-year history. This meeting has given people who do data analysis, mathematical modeling, and HIV evolutionary analyses a specific opportunity to come together to discuss new research, both in terms of new studies and their implications, and new analysis tools and methods that could be applied to HIV. Mathematical and statistical aspects of the work can be discussed in greater depth than is possible in the larger HIV meetings, which primarily focus on experimental and clinical presentations. Historically this meeting has alternated venues between Europe and the US, to allow greater access to the meeting for researchers on both sides of the Atlantic. It can be one of the most important meetings of the year for HIV-scientists directly involved in the analysis of data. The meeting draws individuals who model in vivo dynamics and disease progression, global variation of HIV with considerations of the epidemic history, immunology and vaccine strategies, and individuals that study the emergence of drug resistance. The talks and posters range from important new studies that have complex aspects that may be presented more from a traditional view, but are discussed from an analysis perspective; mathematical oriented talks with an opportunity to go into more detail than is appropriate at typical HIV biology meetings; and talks from scientists outside the HIV field who develop new analysis methods that might usefully be brought into the sphere of HIV research. On the order of 100 to 150 scientists attend; this number has depended on the venue in the past. There is ample time for discussion and developing contacts to facilitate and extend ongoing studies, and to initiate new collaborative efforts. The meeting has traditionally been supported by the OAR and the CDC with supplemental funding coming in through industry and the fund raising efforts of the primary organizer in any given year. For the first time, we are asking for continuing, five-year support from NIH-NIAID, starting with the spring 2003 meeting to be held at Lake Arrowhead conference center. The UCSD Office of Continuing Medical Education has offered to support the financial and organizational infrastructure of the conference for the five-year period for which we are requesting funding, and will work directly with the primary scientific organizer regardless of his or her home institution.